A citation-based method for searching scientific literature

Himani Galagali, John K Kim. Curr Opin Cell Biol 2020
Times Cited: 14







List of co-cited articles
3 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Nuclear export of microRNA precursors.
Elsebet Lund, Stephan Güttinger, Angelo Calado, James E Dahlberg, Ulrike Kutay. Science 2004
14

The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC.
Marc R Fabian, Nahum Sonenberg. Nat Struct Mol Biol 2012
605
14

Targeted tumor therapy with the TGF-beta 2 antisense compound AP 12009.
Karl-Hermann Schlingensiepen, Reimar Schlingensiepen, Andreas Steinbrecher, Peter Hau, Ulrich Bogdahn, Birgit Fischer-Blass, Piotr Jachimczak. Cytokine Growth Factor Rev 2006
127
7

High TGFbeta-Smad activity confers poor prognosis in glioma patients and promotes cell proliferation depending on the methylation of the PDGF-B gene.
Alejandra Bruna, Rachel S Darken, Federico Rojo, Alberto Ocaña, Silvia Peñuelas, Alexandra Arias, Raquel Paris, Avelina Tortosa, Jaume Mora, Jose Baselga,[...]. Cancer Cell 2007
375
7

A Novel Epigenetic Signature for Early Diagnosis in Lung Cancer.
Angel Diaz-Lagares, Jesus Mendez-Gonzalez, David Hervas, Maria Saigi, Maria J Pajares, Diana Garcia, Ana B Crujerias, Ruben Pio, Luis M Montuenga, Javier Zulueta,[...]. Clin Cancer Res 2016
76
7



Long Chain Non-Coding RNA (lncRNA) HOTAIR Knockdown Increases miR-454-3p to Suppress Gastric Cancer Growth by Targeting STAT3/Cyclin D1.
Datong Jiang, He Li, Heping Xiang, Ming Gao, Chunlin Yin, Haiping Wang, Yuansong Sun, Maoming Xiong. Med Sci Monit 2019
27
7

miR-410 induces both epithelial-mesenchymal transition and radioresistance through activation of the PI3K/mTOR pathway in non-small cell lung cancer.
Yue Yuan, Hu Liao, Qiang Pu, Xixian Ke, Xueting Hu, Yongfang Ma, Xinmei Luo, Qianqian Jiang, Yi Gong, Min Wu,[...]. Signal Transduct Target Ther 2020
20
7

Lung cancer epigenetics: From knowledge to applications.
Michaël Duruisseaux, Manel Esteller. Semin Cancer Biol 2018
146
7

Genetic analysis of the mammalian transforming growth factor-beta superfamily.
Hua Chang, Chester W Brown, Martin M Matzuk. Endocr Rev 2002
575
7


Multiomics profiling of primary lung cancers and distant metastases reveals immunosuppression as a common characteristic of tumor cells with metastatic plasticity.
Won-Chul Lee, Alexandre Reuben, Xin Hu, Nicholas McGranahan, Runzhe Chen, Ali Jalali, Marcelo V Negrao, Shawna M Hubert, Chad Tang, Chia-Chin Wu,[...]. Genome Biol 2020
13
7

Lung cancer epidemiology: contemporary and future challenges worldwide.
Joanna Didkowska, Urszula Wojciechowska, Marta Mańczuk, Jakub Łobaszewski. Ann Transl Med 2016
200
7

The Roles of MicroRNA in Lung Cancer.
Kuan-Li Wu, Ying-Ming Tsai, Chi-Tun Lien, Po-Lin Kuo, And Jen-Yu Hung. Int J Mol Sci 2019
110
7


The antisense oligonucleotide trabedersen (AP 12009) for the targeted inhibition of TGF-β2.
Frank Jaschinski, Tanja Rothhammer, Piotr Jachimczak, Christian Seitz, Anneliese Schneider, Karl-Hermann Schlingensiepen. Curr Pharm Biotechnol 2011
53
7

TGF-beta signaling in tumor suppression and cancer progression.
R Derynck, R J Akhurst, A Balmain. Nat Genet 2001
7

miR-454-3p exerts tumor-suppressive functions by down-regulation of NFATc2 in glioblastoma.
Jiandong Zuo, Huimei Yu, Peng Xie, Wenguang Liu, Kai Wang, Hongzao Ni. Gene 2019
20
7

Targeted therapy for high-grade glioma with the TGF-β2 inhibitor trabedersen: results of a randomized and controlled phase IIb study.
U Bogdahn, P Hau, G Stockhammer, N K Venkataramana, A K Mahapatra, A Suri, A Balasubramaniam, S Nair, V Oliushine, V Parfenov,[...]. Neuro Oncol 2011
255
7


Predictors of death, local recurrence, and distant metastasis in completely resected pathological stage-I non-small-cell lung cancer.
Jung-Jyh Hung, Wen-Juei Jeng, Wen-Hu Hsu, Teh-Ying Chou, Biing-Shiun Huang, Yu-Chung Wu. J Thorac Oncol 2012
73
7

MiR-454-3p-Mediated Wnt/β-catenin Signaling Antagonists Suppression Promotes Breast Cancer Metastasis.
Liangliang Ren, Han Chen, Junwei Song, Xuhong Chen, Chun Lin, Xiaolan Zhang, Ning Hou, Jinyuan Pan, Zhongqiu Zhou, Lan Wang,[...]. Theranostics 2019
66
7

EMT: Mechanisms and therapeutic implications.
Mohini Singh, Nicolas Yelle, Chitra Venugopal, Sheila K Singh. Pharmacol Ther 2018
205
7

MicroRNA in lung cancer: role, mechanisms, pathways and therapeutic relevance.
Mohammad Askandar Iqbal, Shweta Arora, Gopinath Prakasam, George A Calin, Mansoor Ali Syed. Mol Aspects Med 2019
171
7

Tumor suppressive microRNA-200a inhibits renal cell carcinoma development by directly targeting TGFB2.
Ruijing Lu, Ziliang Ji, Xiaoqing Li, Jie Qin, Guanghui Cui, Jing Chen, Qingna Zhai, Chunjuan Zhao, Wei Zhang, Zhendong Yu. Tumour Biol 2015
20
7

TGFB2 serves as a link between epithelial-mesenchymal transition and tumor mutation burden in gastric cancer.
BoWen Yang, Jin Bai, Ruichuan Shi, Xinye Shao, Yujing Yang, Yue Jin, Xiaofang Che, Ye Zhang, Xiujuan Qu, Yunpeng Liu,[...]. Int Immunopharmacol 2020
11
9


Mechanisms of TGFβ-Induced Epithelial-Mesenchymal Transition.
Aristidis Moustakas, Carl-Henrik Heldin. J Clin Med 2016
158
7

Cancer statistics, 2020.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2020
7

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
7


Strategies to Modulate MicroRNA Functions for the Treatment of Cancer or Organ Injury.
Tae Jin Lee, Xiaoyi Yuan, Keith Kerr, Ji Young Yoo, Dong H Kim, Balveen Kaur, Holger K Eltzschig. Pharmacol Rev 2020
24
7

Wound-healing assay.
Luis G Rodriguez, Xiaoyang Wu, Jun-Lin Guan. Methods Mol Biol 2005
369
7



TGFbeta1, TGFbeta2, and TGFbeta3 protein expression in gastric carcinomas: correlation with prognostics factors and patient survival.
Konstantinos Vagenas, Charalambos Spyropoulos, Vasiliki Gavala, Athanassios C Tsamandas. J Surg Res 2007
48
7


MiRNA-based Therapeutics for Lung Cancer.
Miaowei Wu, Guosheng Wang, Wei Tian, Yongchuan Deng, Yibing Xu. Curr Pharm Des 2018
37
7

ΔNp63α Suppresses TGFB2 Expression and RHOA Activity to Drive Cell Proliferation in Squamous Cell Carcinomas.
Christopher G Abraham, Michael P Ludwig, Zdenek Andrysik, Ahwan Pandey, Molishree Joshi, Matthew D Galbraith, Kelly D Sullivan, Joaquin M Espinosa. Cell Rep 2018
24
7



Beyond Palliation: The Rationale for Metastasis-Directed Therapy for Metastatic Non-Small Cell Lung Cancer.
Corey C Foster, Sean P Pitroda, Ralph R Weichselbaum. J Thorac Oncol 2019
4
25

Transforming growth factor beta 2: a predictive marker for breast cancer.
Heena Dave, Sunil Trivedi, Manoj Shah, Shilin Shukla. Indian J Exp Biol 2011
16
7


Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, in Advanced Solid Tumors.
Julius Strauss, Christopher R Heery, Jeffrey Schlom, Ravi A Madan, Liang Cao, Zhigang Kang, Elizabeth Lamping, Jennifer L Marté, Renee N Donahue, Italia Grenga,[...]. Clin Cancer Res 2018
199
7

miR-454-3p promotes proliferation and induces apoptosis in human cervical cancer cells by targeting TRIM3.
Yu Song, Qisang Guo, Shujun Gao, Keqin Hua. Biochem Biophys Res Commun 2019
23
7

MiR-454-3p and miR-374b-5p suppress migration and invasion of bladder cancer cells through targetting ZEB2.
Suogang Wang, Geng Zhang, Wanxiang Zheng, Qin Xue, Di Wei, Yu Zheng, Jianlin Yuan. Biosci Rep 2018
36
7

WNT-5A: signaling and functions in health and disease.
Kuldeep Kumawat, Reinoud Gosens. Cell Mol Life Sci 2016
95
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.